Thus, replacement with lipoic acid [40] and/or PDH boosting agents such as dichloroacetate (DCA) [41] or thiamine [42] may help as complementary therapies in PKAN. This evidence concerns the gene PDP1 and pantothenate kinase-associated neurodegeneration.